Heineken warns of potential beer sales drop due to weight-loss drugs

• Heineken, the world's second largest brewer, has warned British pubs about a potential drop in beer sales.
• The warning is due to the increasing popularity of weight-loss drugs, particularly GLP-1 drugs like Ozempic and Wegovy.
• These drugs are believed to reduce the desire to drink alcohol, impacting beer and cider sales.
• Heineken shared this concern in a presentation to British hospitality customers earlier this month.
• The presentation highlighted the potential economic impact on the beer industry.